Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

EAF1 Antibody

Product Specifications

Background

EAF1 acts as a transcriptional transactivator of ELL and ELL2 elongation activities.

NCBI Gene ID

85403

Swiss Prot

Q96JC9

Accession Number

Q96JC9

Host

Rabbit

Reactivity

Human

Immunogen

This EAF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 58-85 amino acids from the Central region of human EAF1.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Other

Purification

This antibody is purified through a protein A column, followed by peptide affinity purification.

Concentration

Batch dependent

Homology

Predicted species reactivity based on immunogen sequence: Mouse

Buffer

Supplied in PBS with 0.09% (W/V) sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Calculated Molecular Weight

29 kDa

Fragment

Rabbit Ig

Applications Notes

For WB starting dilution is: 1:1000

Symbol

EAF1

NCBI Official Name

ELL-associated factor 1

NCBI Organism

Homo sapiens

Background Reference 01

Wan, X., et al. PLoS ONE (2), E9118 (2010) :

Background Reference 02

Jiang, F., et al. Cancer Lett. 253 (2) :265-272 (2007)

Background Reference 03

Sugiyama, N., et al. Mol. Cell Proteomics 6 (6) :1103-1109 (2007)

Background Reference 04

Olsen, J.V., et al. Cell 127 (3) :635-648 (2006)

Other Product Names

ELL-associated factor 1, EAF1

Tested Applications

WB

Protein ID

73919265

Physical Properties

Liquid

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

VAMP4 Blocking Peptide
MBS9620660-01 1 mg

VAMP4 Blocking Peptide

Ask
View Details
VAMP4 Blocking Peptide
MBS9620660-02 5x 1 mg

VAMP4 Blocking Peptide

Ask
View Details
(-) -Epiafzelechin
HY-N0943-01 1 mg

(-) -Epiafzelechin

Ask
View Details
(-) -Epiafzelechin
HY-N0943-02 5 mg

(-) -Epiafzelechin

Ask
View Details
ARG1 (Liver-type arginase, Type I arginase)
144198 100 µg

ARG1 (Liver-type arginase, Type I arginase)

Ask
View Details
Granzyme B (C11, Cathespin G Like 1, CCP1, CGL1, CSPB, CTLA1,CTSGL1, Cytotoxic serine protease B, Cytotoxic T Lymphocyte Cytotoxic T lymphocyte proteinase 2, EC 3.4.21.79, Fragmentin 2, Granzyme 2, GRB, GZMB, HLP, Human lymphocyte protein, Lymphocyte prot
MBS6507608-01 0.1 mg

Granzyme B (C11, Cathespin G Like 1, CCP1, CGL1, CSPB, CTLA1,CTSGL1, Cytotoxic serine protease B, Cytotoxic T Lymphocyte Cytotoxic T lymphocyte proteinase 2, EC 3.4.21.79, Fragmentin 2, Granzyme 2, GRB, GZMB, HLP, Human lymphocyte protein, Lymphocyte prot

Ask
View Details